Why Is NuEnergy Gas (ASX:NGY) Stock Up 5% Today?

Sonal Goyal

23 October 2026 01:21 PM AEDT

Why Is NuEnergy Gas (ASX:NGY) Stock Up 5% Today?

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

NuEnergy Gas (ASX:NGY) shares were up 5.00% at $0.021 at 12:04 pm on 23 October 2026, while the S&P/ASX 200 was down 0.35%.
The annual report dated 29 September 2026 showed a net loss of $730,855 and cash of $552,509 at 30 June 2026.
First gas sales from the 1 MMSCFD Early Gas Sales Initiative at Tanjung Enim are targeted for the first quarter of calendar 2027.

Shares in NuEnergy Gas Limited (ASX:NGY) were up 5.00% at $0.021 during the trading session on 23 October 2026, as at 12:04 pm, while the S&P/ASX 200 stood at 8,762.60, down 0.35% (30.60 points). NuEnergy is an independent energy company focused on coal bed methane (CBM) in Indonesia, with four production sharing contracts in South Sumatra. Its latest update is the 2026 annual report dated 29 September 2026, which covers the year ended 30 June 2026 and sets out progress at the Tanjung Enim project.

Annual Results and Balance Sheet Position

In its 2026 annual report dated 29 September 2026, NuEnergy reported a net loss after tax attributable to owners of $730,855 for the year ended 30 June 2026, compared with a loss of $941,120 a year earlier. The company attributed the lower loss mainly to foreign exchange gains.

Cash and cash equivalents were $552,509 at 30 June 2026, against $2,434,673 a year earlier. Net assets attributable to owners rose from $31.5 million to $32.1 million, mainly due to a rights issue.

Tanjung Enim Early Gas Sales Initiative

The annual report dated 29 September 2026 states that Tanjung Enim plan of development 1 targets production of 25 million standard cubic feet per day (MMSCFD) in two phases. The first phase, the Early Gas Sales Initiative (EGSI), is 1 MMSCFD from four wells, all of which were drilled by November 2025. Dewatering and gas flaring have continued across the wells.

NuEnergy signed a binding gas sales and purchase agreement with PT Perusahaan Gas Negara Tbk on 17 December 2025. First gas sales are now targeted for the first quarter of calendar 2027, with the company citing weather-related disruptions and permitting requirements. Preparations for the early production facilities began after year end.

Funding Arrangements and Government Recognition

The report dated 29 September 2026 details a private placement completed on 11 September 2026, raising $3.05 million through 80.2 million shares at $0.038. Unlisted options carry a $0.06 exercise price and expire on 10 September 2028. Earlier, a rights issue at $0.025 raised $3,427,364.

For the second phase, NuEnergy signed a collaboration agreement with PT Beijing Energy Linking on 8 January 2026 and a field service contract in June 2026 valued at US$88 million for Tanjung Enim Area A. At the end of August 2026, the Indonesian President approved Tanjung Enim as a National Strategic Project.

About the Company and Business Overview

NuEnergy Gas Limited was incorporated in Western Australia on 26 March 1985, is listed on the Australian Securities Exchange under the code NGY. Its principal activities are the exploration, appraisal and development of CBM.

The company holds 2,278 square kilometres of acreage under four production sharing contracts in South Sumatra and operates all of them: Tanjung Enim (45% interest), Muara Enim (40%), Muralim (100%) and Muara Enim II (30%). A total of 29 wells have been drilled. Certified Tanjung Enim reserves in the plan of development area total about 164.89 billion cubic feet. The company has no cash-generating assets and no dividend policy.

Related Sector Context

NuEnergy operates in the energy sector, specifically unconventional natural gas in Indonesia. The company's report describes the country as facing a gas supply shortage and notes that conventional production is declining. Development-stage companies typically spend on drilling and facilities before any revenue is generated.

Against this backdrop, the S&P/ASX 200 stood at 8,762.60, down 0.35%, at 12:04 pm on 23 October 2026, while NuEnergy shares were up 5.00%.

Risks to Weigh In

The annual report lists ongoing capital needs as a key risk, noting that further funding is required. The directors' cash flow forecast to 30 September 2027 assumes planned capital raising of $4,000,000 and early gas sales proceeds of $1,166,000. Related-party amounts of $5,507,007 are backed by shareholder support letters.

Other risks identified include failure to meet production sharing contract work commitments, the need to secure plans of development before deadlines, reserve and resource estimate uncertainty, and delays migrating resources to reserves. The company also disclosed a demand from a former director and chief executive, Dr Ian Wang, claiming $1.1 million in unpaid remuneration, of which $195,650 is accrued.

Catalysts on Watch

The report points to construction of the early production facilities, first gas sales targeted for the first quarter of calendar 2027, and progress under the field service contract for the 24 MMSCFD second phase. Plan of development preparations continue at Muralim and Muara Enim, each granted a 12-month extension from 13 August 2026.

Where Things Stand

NuEnergy's shares were up 5.00% at $0.021 at 12:04 pm on 23 October 2026. The company's most recent filing, dated 29 September 2026, shows a pre-revenue CBM developer with a net loss of $730,855, cash of $552,509 and a first gas sales target in the first quarter of calendar 2027.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.